Raquel Sanchez-Valle
Neurology Department NeurologistAbout me
I completed my training as a neurologist at the Hospital Clínic de Barcelona (2000) and my PhD degree on Biopathology in Medicine at the University of Barcelona (UB) (2003). After this, I obtained a Rio Hortega fellowship (ISCIII, Spanish Ministry of Health) in Behavioural neurology at IDIBAPS. I accomplished a short-term postdoctoral scholarship at the Memory and Aging Center- University of California San Francisco, directed by Dr. Bruce Miller (2006). In june 2006, I was appointed as Neurologist at the Neurology Service of the Hospital Clínic de Barcelona. Since 2018, I am the Group Leader of the Alzheimer’s Disease and other Cognitive Disorders group at the IDIBAPS and Associate professor at the UB (2018). From 2018 to 2023, I was the Head of the Neurology Service at the Hospital Clínic
Featured publications
-
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data
Authors:Reference: Human Brain Mapping 2023. -
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study
Authors:Reference: Journal Of Neurology 2023. -
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort
Authors:Reference: Neurology 2023. -
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects
Authors:Reference: Neuropsychology 2023. -
The APOE4 effect: Structural brain differences in Alzheimer's disease according to the age at symptom onset
Authors:Reference: European Journal Of Neurology 2023. -
Sex differences in early-onset Alzheimer's disease
Authors:Reference: European Journal Of Neurology 2022. -
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Authors:Reference: Nature Medicine 2022. -
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome
Authors:Reference: Frontiers In Immunology 2022. -
Barcelona scale for buccophonatory apraxia: quantitative assessment tool
Authors:Reference: Neurologia 2022. -
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
Authors:Reference: Alzheimers & Dementia 2020.
Featured Projects
-
Genetic dementias (genetic Alzheimer’s disease, frontotemporal dementia and prion diseases):longitudinal changes and expression and epigenetic differences with sporadic cases.
Principal investigator: Raquel Sanchez del Valle DíazFunder: Instituto de Salud Carlos IIICode: PI20/ 00448Duration: 01/01/2021 - 30/06/2025 -
Estudio de biomarcadores y desarrollo de nuevas estrategias terapéuticas en una cohorte multicéntrica de Demencia Frontotemporal.
Principal investigator: Raquel Sanchez del Valle DíazFunder: Departament de Salut de la Generalitat de Catalunya ; 4.12.01 - Malaltia d'Alzheimer i altres trastorns cognitius. Institut d'Investigacions Biomèdiques August Pi i Sunyer (Otros)Code: SLT002/16/00408Duration: 27/03/2017 - 31/12/2023 -
Study of genetic frontotemporal dementia in preclinical and early stages of the disease: cognitive performance, structural and functional neuroimaging and biochemical markers.
Principal investigator: Raquel Sanchez del Valle DíazFunder: Fundació La Marató de TV3Code: TV3-20143810Duration: 15/05/2015 - 15/11/2021 -
Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Principal investigator: Raquel Sanchez del Valle DíazFunder: National Institute on Aging (NIH)Duration: 14/07/2014 -
Alzheimer’s Disease Prediction Service (ADPS): digital biomarker for Real-World Evidence (RWE) in AD
Principal investigator: Raquel Sanchez del Valle DíazFunder: EIT HealthCode: EIT Health 18066/2017Duration: 01/01/2018 - 31/12/2018